Gibson Dunn and Wachtell advise on Abbot’s $25 billion purchase of St. Jude Medical
Gibson, Dunn & Crutcher represented medical device company St. Jude Medical in its agreed sale to global healthcare company Abbott for $25 billion. Per terms of the deal, St. Jude shareholders will receive $46.75 in cash and 0.8708 shares in Abbott for each share they own in St. Jude. The deal values St. Jude at $85 per share. Abbott, based in Abbott Park, Ill., will assume or refinance the $5.7 billion of debt belonging to St. Jude.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
